Single-use Bioprocessing Market: Size, Share, Growth Trends & Forecast 2035

The global Single-use Bioprocessing Market is witnessing significant growth as biopharmaceutical manufacturers increasingly adopt disposable technologies to improve manufacturing efficiency, minimize contamination risks, and accelerate product development. Single-use systems have become a preferred solution for biologics production due to their flexibility, reduced operational costs, and ability to support faster production cycles.

According to Quintile Reports, the global Single-use Bioprocessing Market was valued at USD 36.13 billion in 2026 and is projected to reach USD 158.58 billion by 2035, registering a CAGR of 15.94% during the forecast period.

The market is primarily driven by the increasing production of biologics, monoclonal antibodies, vaccines, biosimilars, and advanced cell and gene therapies. Growing investments in biotechnology research, expanding contract development and manufacturing organizations (CDMOs), and the need for flexible manufacturing platforms are accelerating the adoption of single-use technologies across the pharmaceutical industry.

Single-use bioprocessing equipment—including disposable bioreactors, filtration systems, media bags, tubing assemblies, mixers, and sampling systems—offers numerous advantages over conventional stainless-steel systems. These include reduced cleaning and validation requirements, lower capital expenditure, shorter production turnaround times, improved sterility assurance, and greater manufacturing flexibility.

North America continues to dominate the market owing to its well-established biopharmaceutical infrastructure, strong presence of leading biotechnology companies, and favorable regulatory support. Europe remains a major contributor through continuous innovation in biomanufacturing technologies, while Asia-Pacific is expected to experience the fastest growth due to expanding biologics manufacturing capacity, government support for biotechnology, and increasing investments across China, India, Japan, and South Korea.

Technological advancements such as automated bioprocess control, smart sensors, digital monitoring platforms, and integrated single-use manufacturing systems are transforming production capabilities and improving process efficiency. As pharmaceutical companies focus on personalized medicine and next-generation biologics, demand for scalable and modular manufacturing solutions is expected to continue rising.

Leading companies operating in the market include Thermo Fisher Scientific, Sartorius AG, Danaher Corporation, Merck KGaA, Pall Corporation, Cytiva, Repligen Corporation, Corning Incorporated, Eppendorf AG, Parker Hannifin Corporation, West Pharmaceutical Services, Nova Biomedical Corporation, Tosoh Corporation, and Celltainer Bio. These companies continue to invest in product innovation, strategic partnerships, manufacturing expansion, and advanced automation technologies to strengthen their competitive position.

The future of the Single-use Bioprocessing Market remains highly promising, supported by increasing demand for biologics, expanding biopharmaceutical manufacturing capacity, and continuous advancements in disposable processing technologies. Organizations adopting innovative single-use solutions are expected to improve operational efficiency, reduce production costs, and accelerate the commercialization of life-saving therapies.

For comprehensive market forecasts, competitive analysis, regional insights, company profiles, and emerging industry opportunities, explore the complete Single-use Bioprocessing Market report from Quintile Reports.

www.quintilereports.com/industry-report/1082-single-use-bioprocessing-market/